Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson’s disease
Makoto Hideshima, Yasuyoshi Kimura, César Aguirre, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

Natural Antioxidant Compounds as Potential Pharmaceutical Tools against Neurodegenerative Diseases
Attilio Marino, Matteo Battaglini, Nadia Moles, et al.
ACS Omega (2022) Vol. 7, Iss. 30, pp. 25974-25990
Open Access | Times Cited: 70
Alpha Synuclein: Neurodegeneration and Inflammation
Gianluigi Forloni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5914-5914
Open Access | Times Cited: 54
A Review on Natural Antioxidants for Their Role in the Treatment of Parkinson’s Disease
Pooja Mittal, Sanchit Dhankhar, Samrat Chauhan, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 908-908
Open Access | Times Cited: 37
Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson’s Disease
Samuel Peña‐Díaz, Javier García‐Pardo, Salvador Ventura
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 839-839
Open Access | Times Cited: 27
Lysophagy protects against propagation of α-synuclein aggregation through ruptured lysosomal vesicles
Keita Kakuda, Kensuke Ikenaka, Akiko Kuma, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 121, Iss. 1
Open Access | Times Cited: 18
Alkaloids extracted from Dendrobium officinale grown in diverse environments exhibited robust antioxidative and antiaging activity
Yichen Liu, Arome Solomon Odiba, Qi Yu, et al.
Journal of Future Foods (2025) Vol. 5, Iss. 6, pp. 591-604
Closed Access
Therapeutic potential and limitation of condensed and hydrolyzed tannins in Parkinson's disease
Ran Zhao, Nan Jia, Shuyang Wu, et al.
International Journal of Biological Macromolecules (2025), pp. 141814-141814
Closed Access
Effects on neuroprotection and α-synuclein expression of a Canna coccinea rhizome extract
Viviana Graciela Spotorno, Mariana Roxo, Bernhard Wetterauer, et al.
Fitoterapia (2025) Vol. 181, pp. 106380-106380
Closed Access
Targeting the ClpP-αSynuclein Interaction with a Decoy Peptide to Mitigate Neuropathology in Parkinson's Disease Models
Di Hu, Xiaoyan Sun, Xin Qi
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
PACSIN1 is indispensable for amphisome-lysosome fusion during basal autophagy and subsets of selective autophagy
Yukako Oe, Keita Kakuda, Shin‐ichiro Yoshimura, et al.
PLoS Genetics (2022) Vol. 18, Iss. 6, pp. e1010264-e1010264
Open Access | Times Cited: 17
Pathological mechanisms and treatment of sporadic Parkinson’s disease: past, present, and future
Hideki Mochizuki
Journal of Neural Transmission (2024) Vol. 131, Iss. 6, pp. 597-607
Open Access | Times Cited: 2
Tannic acid as a biphasic modulator of tau protein liquid–liquid phase separation
Jiani Xiang, Jingxin Chen, Yanqing Liu, et al.
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133578-133578
Closed Access | Times Cited: 2
Insights into the remarkable attenuation of hen egg white lysozyme amyloid fibril formation mediated by biogenic gold nanoparticles stabilized by quercetin-functionalized tara gum
Fredrick Nwude Eze, Roseline Chika Eze, Chitchamai Ovatlarnporn
International Journal of Biological Macromolecules (2022) Vol. 232, pp. 123044-123044
Closed Access | Times Cited: 11
A natural small molecule‐mediated inhibition of alpha‐synuclein aggregation leads to neuroprotection in Caenorhabditis elegans
Tulika Srivastava, Divya Tyagi, Siraj Fatima, et al.
Journal of Neurochemistry (2023) Vol. 168, Iss. 8, pp. 1640-1654
Closed Access | Times Cited: 5
Elegant Nematodes Improve Our Understanding of Human Neuronal Diseases, the Role of Pollutants and Strategies of Resilience
Anna von Mikecz
Environmental Science & Technology (2023) Vol. 57, Iss. 44, pp. 16755-16763
Open Access | Times Cited: 5
Cellular Models of Alpha-Synuclein Aggregation: What Have We Learned and Implications for Future Study
Katrina Albert, Sara Kälvälä, Vili Hakosalo, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2649-2649
Open Access | Times Cited: 7
Identification of DOT1L inhibitor in a screen for factors that promote dopaminergic neuron survival
Jun Cui, Joseph Carey, Renee A. Reijo Pera
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 5
Identification of α-Synuclein Aggregation Inhibitors via High-Throughput Screening
Samuel Peña‐Díaz, Zoe Manglano-Artuñedo, Francisca Pinheiro, et al.
Neuromethods (2024), pp. 61-85
Closed Access
Molecular Mechanisms Underlying Alzheimer’s and Parkinson’s Disease and the Possibility of Their Neutralization
O. V. Nevzglyadova, Е. В. Михайлова, Soĭdla Tr
Cell and Tissue Biology (2023) Vol. 17, Iss. 6, pp. 593-607
Closed Access | Times Cited: 1
Molecular Mechanisms Underlying Alzheimer’s and Parkinson’s Diseases and the Potential Possibility of their Neutralization
O. V. Nevzglyadova, Е. В. Михайлова, Soĭdla Tr
Tsitologiya (2023) Vol. 65, Iss. 4, pp. 323-338
Closed Access | Times Cited: 1
Amyloid polymorphs and pathological diversities
Ronald Melki
Neurochemistry International (2022) Vol. 156, pp. 105335-105335
Open Access
Identification of DOT1L Inhibitor in a Screen for Factors that Promote Dopaminergic Neuron Survival
Jun Cui, Joseph Carey, Renee A. Reijo Pera
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top